IMPACT FACTOR: 1.2
Short Name: Hematol Oncol Curr Res
Publisher: MedDocs Publishers LLC
Factor XI (FXI) is a blood coagulation protease involved in the coagulation cascade, activating the Factor IX and contributing to hemostasis. Its deficiency is associated with mild to moderate bleeding manifestations that typically occur after injury, mainly in tissues containing activators of the fibrinolysis (urinary tract, oropharynx).
Solitary plasmacytomas occur most frequently in bones, but can also be seen in soft tissues. The aim of this study was to describe the diagnostic, therapeutic and evolutionary aspects of plasmacytoma. We carried out a retrospective descriptive study from January 2017 to January 2022 in the clinical hematology department in Dakar.
Here we report the diagnostic criteria for these diseases according to the 2022 International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms [1-3], a major revision of the previous editions of the World Health Organization (WHO) publications on the same topic [4-12].
Revascularization of the myocardium under conditions of extracorporeal circulation cause clinical problems related to the effects of the intervention itself on the immune system and inflammatory response, especially systemic inflammatory response (Engl. Systemic Inflammatory Response Syndrome, SIRS)
Multiple Myeloma (MM) is characterized by immunosuppression leading to increased susceptibility to infections. The aim of this study was to evaluate the morbidity and mortality of infections in patients followed for MM.
We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.
